Cybin (HELP) Debt Ratio (2021)
Cybin (HELP) posted quarterly Debt Ratio of 0.03 for Q4 2021, up 822.04% on a QoQ basis from 0.0 in Q3 2021.
Cybin (HELP) Debt Ratio (2021) Analysis & Trends
Cybin (HELP) has reported Debt Ratio for 1 consecutive years, with 0.03 the latest figure, recorded in Q4 2021.
- Quarterly Debt Ratio changed N/A year-over-year to 0.03 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.03 (changed N/A YoY) and the FY2021 annual result came in at 0.01, changed N/A from the prior year.
- Debt Ratio advanced to 0.03 in Q4 2021 per HELP's latest filing, from 0.0 in the prior quarter.
- Over the last five years, Debt Ratio for HELP reached as high as 0.03 in Q4 2021 and fell as low as 0.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |